Media Centre

Featured Media Release
 

25 Jul 2013 - GSK to Trial Poppy Growing in Victoria

GlaxoSmithKline (GSK) Australia announced today that small scientific trials of poppies, used as a source of medicinal alkaloids, have commenced in Victoria following the Victorian Government granted approval.

 
 

Media Releases


GSK statement on affordability of vaccines in developing countries

Around 80% of all of GSK’s vaccines, including our pneumococcal vaccine, are provided to developing countries at a substantial discount to western prices. GSK offers the lowest prices to Gavi and UNICEF which can be as little as a tenth of developed...

20/01/2015

 

ADELAIDE HILLS BUSHFIRES: Donation of asthma medication

GSK has responded to the South Australian bushfire emergency by providing eight pharmacies in the Adelaide Hills fire affected areas with a donation of asthma rescue medicine.

08/01/2015

 

Anoro® Ellipta® (umeclidinium/vilanterol) to be reimbursed in Australia for Chronic Obstructive Pulmonary Disease

GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) have welcomed news that Anoro Ellipta (umeclidinium/vilanterol) will be reimbursed via the Australian Pharmaceutical Benefits Scheme (PBS) as a long-term once-daily, maintenance...

01/12/2014

 

Breo® Ellipta® (fluticasone furoate/vilanterol) to be PBS listed as reimbursed treatment for asthma and COPD

Affordable treatment options for Australian patients with asthma and chronic obstructive pulmonary disease (COPD) are set to expand with GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) announcing the listing of Breo Ellipta on the...

01/12/2014

 

Incruse® Ellipta® (umeclidinium) to be reimbursed in Australia for Chronic Obstructive Pulmonary Disease

GlaxoSmithKline (GSK) has welcomed the listing of Incruse Ellipta (umeclidinium) on the Australian Pharmaceutical Benefits Scheme (PBS) from December 1st 2014 as a long term once-daily, maintenance bronchodilator treatment to relieve symptoms in...

01/12/2014

 

GSK leads Access to Medicines Index 2014

The Access to Medicines Index published today has ranked GSK top for the fourth consecutive time.

17/11/2014

 

GSK announces multi-million dollar investment in next generation manufacturing

GSK Australia has announced today it will be investing AUD$31 million in next generation manufacturing technology to expand its Boronia site in the outer eastern suburbs of Melbourne.

14/11/2014

 

GSK transitions to online versions of Consumer Medicine Information (CMI) leaflets for prescription only medicines

To ensure we provide the most up-to-date consumer medicine information (CMI) to patients, GSK will no longer be providing CMI leaflets in medicine packs, including sample packs.

10/11/2014

 

Plant drugs and snail venom: Revolutionary drug research wins GSK award

20-year research program acknowledged with prestigious $80,000 GSK Award for Research Excellence

06/11/2014

 

Pharmacy/Wholesaler level recall of two batches of Zovirax® Ophthalmic Ointment (aciclovir 3%)

GSK Australia, in consultation with the Therapeutic Goods Administration (TGA), is initiating a voluntary pharmacy/wholesaler level recall of two batches of Zovirax® Ophthalmic Ointment (aciclovir 3%).

27/10/2014

1 2 3 4 5 6 7 8 9 10 11 >